Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
8383 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Talks at GS
View all
Exchanges
981 Listeners
Masters in Business
2,165 Listeners
The Meb Faber Show - Better Investing
937 Listeners
Capital Allocators – Inside the Institutional Investment Industry
796 Listeners
UBS On-Air: Market Moves
179 Listeners
Making Sense
59 Listeners
Value Investing with Legends
213 Listeners
Thoughts on the Market
1,294 Listeners
At Any Rate
77 Listeners
The Memo by Howard Marks
435 Listeners
The Insight by Oaktree Capital
21 Listeners
The Markets
76 Listeners
The View From Apollo
25 Listeners
Joys of Compounding
97 Listeners
Bloomberg Talks
22 Listeners